Stay updated on Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.

Latest updates to the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page
- Check3 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3; this is a minor site version update with no visible changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA dedicated Locations section now lists California and Florida sites for the study. The previous 'California Locations' and 'Florida Locations' entries and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.4%

- Check53 days agoChange DetectedFooter Revision updated from v3.2.0 to v3.3.2 with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe site-wide government funding status notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedThe screenshots show only minor UI/layout updates and banner changes, with no modifications to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check103 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference5%

Stay in the know with updates to Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.